Real-World Use and Appropriateness of Coronary Interventions for Chronic Total Occlusion (from a Japanese Multicenter

Taku Inohara1, Shun Kohsaka1, Hiroaki Miyata2

  • 1Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.

Insights

Chronic total occlusion percutaneous coronary intervention (CTO-PCI) is performed in about 10% of elective PCI cases. While CTO-PCI indications are relatively appropriate, outcomes show lower success and higher complication rates compared to non-CTO PCI.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Health Services Research

Background:

  • Outcomes and indications for chronic total occlusion percutaneous coronary intervention (CTO-PCI) are not well-established outside high-volume centers.
  • Real-world data on CTO-PCI clinical outcomes and appropriateness are limited.

Purpose of the Study:

  • To provide a real-world overview of clinical outcomes and appropriateness of PCI for CTO.
  • To assess the appropriateness of CTO-PCI indications based on established criteria.

Main Methods:

  • Analysis of 4,950 consecutive PCIs for nonacute indications from a multicenter Japanese PCI registry (in collaboration with Cath-PCI).
  • Inclusion of 501 CTO-PCI cases (10.1% of total) for outcome and appropriateness assessment.
  • Evaluation of indication appropriateness using 2012 appropriate use criteria for revascularization.

Main Results:

  • CTO-PCI procedural success rate was 76% with a major adverse cardiac event rate of 3.2%.
  • CTO-PCIs had more appropriate indications compared to non-CTO PCIs (lower inappropriate indication rate: 23.0% vs 31.4%, p=0.04).
  • Only 17% of CTO-PCIs mapped directly to CTO-specific scenarios; others mapped to non-CTO scenarios.

Conclusions:

  • Approximately 10% of elective PCIs in this registry were for CTO lesions.
  • CTO-PCI demonstrated lower procedural success and higher complication rates than non-CTO PCI.
  • Findings highlight the need for improved clinical scenarios and evaluation for CTO-PCI.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
861
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
456
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
419
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
473
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
579
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.7K